TransMedics Group, Inc. - Common Stock (TMDX)
72.14
0.00 (0.00%)
Transmedics Group Inc is a biotechnology company focused on revolutionizing the organ transplant process through innovative medical technologies
They have developed a unique organ preservation and transportation system that optimizes the viability of donor organs, specifically targeting hearts, lungs, and livers. By employing advanced perfusion technology, Transmedics aims to improve patient outcomes and increase the availability of transplantable organs, ultimately addressing the critical shortages faced in the transplant community. Their commitment to enhancing the transplant experience positions them as a leader in the field of organ transplantation.
Frequently Asked Questions
Is TransMedics Group, Inc. - Common Stock publicly traded?
Yes, TransMedics Group, Inc. - Common Stock is publicly traded.
What exchange does TransMedics Group, Inc. - Common Stock trade on?
TransMedics Group, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TransMedics Group, Inc. - Common Stock?
The ticker symbol for TransMedics Group, Inc. - Common Stock is TMDX on the Nasdaq Stock Market
What is the current price of TransMedics Group, Inc. - Common Stock?
The current price of TransMedics Group, Inc. - Common Stock is 72.14
When was TransMedics Group, Inc. - Common Stock last traded?
The last trade of TransMedics Group, Inc. - Common Stock was at 4:00 pm EST on February 4th, 2025
What is the market capitalization of TransMedics Group, Inc. - Common Stock?
The market capitalization of TransMedics Group, Inc. - Common Stock is 2.35B
How many shares of TransMedics Group, Inc. - Common Stock are outstanding?
TransMedics Group, Inc. - Common Stock has 32.55M shares outstanding.